Application no. and date | 17771348.4 (espacenet) (Federated) (European Patent Register), 20170831 | Patent/reg. no. and date | DK/EP 3507366, 20201007 | Publication date | 20190710 | Priority no. and date | GB 201614858, 20160901, GB 201616374, 20160927, GB 201621467, 20161216, GB 201703034, 20170224, GB 201707508, 20170510 | EP pub. no. and date |
EP 3507366 20190710 | Effective date | | Applicant/owner | ProQR Therapeutics II B.V., Zernikedreef 9
2333 CK Leiden, NL | Applicant ref. no. | V2010-063-DK | Inventor | TURUNEN, Janne Juha, ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, AALTO, Antti, ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, KLEIN, Bart, ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, VAN SINT FIET, Lenka, ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, BOUDET, Julien Auguste Germain, ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/712 (2006.01) , C12N 15/10 (2006.01) , C12N 15/113 (2010.01) | Title | KEMISK MODIFICERET, ENKELTSTRENGEDE RNA-MODIFICERENDE OLIGONUKLEOTIDER | Int. application no. | EP2017071912 | Int. publication no. | WO2018041973 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|